Prevalence of Knowledge, Attitudes and Perception of Covid Vaccine in Iraq. A Cross Sectional Study

NCT ID: NCT05256602

Last Updated: 2022-02-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-07

Study Completion Date

2022-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Numerous scientific agencies and iraqi MOH has advised to promote population vaccination as an attempt to reduce the burden of COVID19. The aim of our study is to evaluate knowledge, Attitude, practice and concerns toward different type of covid19 vaccine of Iraqi population. This will help us concentrate our efforts to increase Willingness of vaccination among southren Iraqi people

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Detailed Description: New human pandemic disease that have large of world population concern and have many challenges that effect on their life directly or indirectly is coronavirus infection (COVID 19).Numerous scientific agencies and iraqi MOH has advised to promote population vaccination as an attempt to reduce the burden of COVID19 so need to evalute knowledge, Attitude, practice and concerns toward different type of covid19 vaccine of iraqi population to increase willing of vaccination among southren Iraqi population to reduce mortality rate of covid19 and searching for incidence vaccination against it. So to decrease complication of covid19 pandemic, they introduced covid19 vaccine that has essential role to maintain our life. So many companies of manufacturing of covid19 vaccine with different ways by using part of viruses spike of protein or whole virus after attenuated but some Iraqi population hesitancy that delay of acceptance in spite of this vaccination is represent one of method to protect themselves from infected with covid19 in addition attended social event ,shaking hands ,leaving place when talking with other person and still wearing of mask.

Important recognition key for prevention and maintain our life is attitude judgment and how to do this to give positive or negative idea about covid19vaccine according to different source of information that concerning like social media ,experience of previous personal , governmental information and health care professional sources Considering lake of studies and research related to covid19 vaccine in Iraq ,so there is urgent need to know refused or hesitant attitude in southern Iraqi population

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Sars-CoV-2 Infection COVID-19 Pandemic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

survey respondant

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Willingness to participate in the study
* Living in southern Iraq

Exclusion Criteria

* Less than18 years
* Not willing to complete the questionnaire
* Unable to complete the questionnaire
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Basra

UNKNOWN

Sponsor Role collaborator

AlFayhaa General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alhasan M Al-Mudhaffe, BCPS

Role: CONTACT

+9647801601693

Doaa Qasim, MSc

Role: CONTACT

009647808071603

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

20222

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.